Seasonal variation of onset in patients with anti-aquaporin-4 antibodies and anti-myelin oligodendrocyte glycoprotein antibody

被引：14

作者：

Akaishi, Tetsuya ^{[1
,2
]}

Fujimori, Juichi ^{[3
]}

Takahashi, Toshiyuki ^{[1
,4
]}

Misu, Tatsuro ^{[1
]}

Takai, Yoshiki ^{[1
]}

Nishiyama, Shuhei ^{[1
]}

Kaneko, Kimihiko ^{[1
]}

Ogawa, Ryo ^{[1
]}

Abe, Michiaki ^{[2
]}

Ishii, Tadashi ^{[2
]}

Aoki, Masashi ^{[1
]}

Fujihara, Kazuo ^{[5
]}

Nakashima, Ichiro ^{[3
]}

机构：

[1] Tohoku Univ, Grad Sch Med, Dept Neurol, Sendai, Miyagi, Japan

[2] Tohoku Univ Hosp, Dept Educ & Support Reg Med, Sendai, Miyagi, Japan

[3] Tohoku Med & Pharmaceut Univ, Dept Neurol, Sendai, Miyagi, Japan

[4] Natl Hosp Org Yonezawa Natl Hosp, Dept Neurol, Yonezawa, Yamagata, Japan

[5] Fukushima Med Univ, Dept Multiple Sclerosis Therapeut, Fukushima, Japan

来源：

JOURNAL OF NEUROIMMUNOLOGY | 2020年 / 349卷

关键词：

Aquapotin-4; Attacks; Myelin-oligodendrocyte glycoprotein; Neuromyelitis optica spectrum disorders; Seasonal distribution; EPSTEIN-BARR-VIRUS; MULTIPLE-SCLEROSIS; RISK;

D O I：

10.1016/j.jneuroim.2020.577431

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

This study aimed to determine the seasonal impact on the clinical onset of inflammatory neurological diseases of the central nervous system by analyzing the onset month with information on clinical manifestations in Japanese patients. As a result, patients with anti-aquaporin-4 antibodies (AQP4-IgG)-positive neuromyelitis optica spec-trum disorders (NMOSD) showed spring-summer predominance of the clinical onset. Conversely, patients with anti-myelin oligodendrocyte glycoprotein antibody (MOG-IgG)-associated disease showed autumn-winter predominance of the clinical onset. Both seasonal variations were irrespective of the clinical manifestation. Environmental factors with seasonal variation influence the development of neurological conditions related to AQP4-IgG and MOG-IgG.

引用

页数：5

共 50 条

[31] Diagnosis and treatment of anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis
Takeshi Kezuka
Hitoshi Ishikawa
Japanese Journal of Ophthalmology, 2018, 62 : 101 - 108
[32] Anti-Myelin Oligodendrocyte Glycoprotein Optic Neuritis or Neuroretinitis?
Lee, Andrew R.
El-Dairi, Mays A.
JAMA OPHTHALMOLOGY, 2018, 136 (10)
[33] A Case of Anti-Myelin Oligodendrocyte Glycoprotein Antibody-Positive Late-Onset Acute Disseminated Encephalomyelitis
Kim, Ki Hoon
Cho, Jinhyuk
Shin, Ha Young
Kim, Seung Woo
JOURNAL OF CLINICAL NEUROLOGY, 2021, 17 (02): : 330 - 332
[34] Anti-myelin oligodendrocyte glycoprotein antibody neuritis optica following anti-NMDA receptor encephalitis
Yokoyama, Koji
Hori, Mutsuki
Yoshida, Akira
PEDIATRICS INTERNATIONAL, 2016, 58 (09) : 953 - 954
[35] Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a Japanese boy with recurrent optic neuritis
Tsuburaya, Rie S.
Miki, Naoki
Tanaka, Keiko
Kageyama, Takashi
Irahara, Kaori
Mukaida, Souichi
Shiraishi, Kazuhiro
Tanaka, Masami
BRAIN & DEVELOPMENT, 2015, 37 (01): : 145 - 148
[36] A case of unilateral recurrent cerebral cortical encephalitis with anti-myelin oligodendrocyte glycoprotein antibodies
Guo, Liying
Yun, Ho
Tan, Xiaomu
Geng, Xiaokun
Ding, Yuchuan
BRAIN CIRCULATION, 2022, 8 (02) : 102 - 107
[37] Hypercomplementemia at relapse in patients with anti-aquaporin-4 antibody
Doi, H.
Matsushita, T.
Isobe, N.
Matsuoka, T.
Minohara, M.
Ochi, H.
Kira, J. I.
MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (03) : 304 - 310
[38] Clinical Profile of Anti-Myelin Oligodendrocyte Glycoprotein Antibody Seropositive Cases of Optic Neuritis
Matsuda, Ryusaku
Kezuka, Takeshi
Umazume, Akihiko
Okunuki, Yoko
Goto, Hiroshi
Tanaka, Keiko
NEURO-OPHTHALMOLOGY, 2015, 39 (05) : 213 - 219
[39] Autoimmune cortical encephalitis in two children with anti-myelin oligodendrocyte glycoprotein (MOG) antibody
Doig, D.
McNamara, C.
Mewasingh, L.
Beri, S.
Jones, B.
Kachramanoglou, C.
Jan, W.
JOURNAL OF NEUROLOGY, 2021, 268 (03) : 1096 - 1101
[40] Hypercomplementemia at relapse in patients with anti-aquaporin-4 antibody
Doi, H.
Matsushita, T.
Isobe, N.
Matsuoka, T.
Minohara, M.
Ochi, H.
Kira, J.
MULTIPLE SCLEROSIS, 2009, 15 (01): : 146 - 146

← 1 2 3 4 5 →